glp 1 effects on mental health GLP-1s may improve some outcomes in addition to lowering body weight Part 2 of a 3-Part
Description
Strengths Proven, widely available, and FDA-approved for weight loss
The trial participants were at very high risk for subsequent cardiovascular events with 68% having had a heart attack (82% had coronary artery disease) and the rest with prior stroke or peripheral arterial disease or a combination of these entry criteria
Abstract Objectives Glucagon-like peptide 1 (GLP-1) receptor agonists have recently proven to be an effective treatment for type 2 diabetes mellitus (T2DM)
Nonetheless, no significant increase in the risk of TOP was observed when the GLP1-RA group was compared with the overweight/obese reference group (HR, 1.79
Bliddal H, Bays H, Czernichow S, et al
almalar, GLP-1 analoglarnn yaam tarz deiiklikleriyle birlikte kullanldnda birka ay iinde vcut arlnn %10-20sini azaltabileceini gstermektedir
